Floatz logo

Cyclophosphamide

Neoplasms, Glandular and Epithelial

Sheba Medical CenterSmall moleculePhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Neoplasms, Glandular and Epithelial cohort.

Asset / SponsorPhaseRating
Sorafenib
Shandong Cancer Hospital and Institute
Phase 3BB
Pembrolizumab
Sheba Medical Center
Phase 2B
Epirubicin
Sheba Medical Center
Phase 2B
Linifanib
Abbott
Phase 3B
Ixabepilone
Cedars-Sinai Medical Center
Phase 2CCC

View all 22 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →